Skip to main content
. 2020 Nov 25;8(2):2003041. doi: 10.1002/advs.202003041

Scheme 1.

Scheme 1

A) The design and preparation of FePSe3@APP@CCM NSs. B) FePSe3@APP@CCM with immune escape and homologous targeting abilities for effective tumor multimodal imaging. C) The mechanism of FePSe3@APP@CCM for synergistic cancer photothermal immunotherapy.